⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Expanded Treatment Protocol (ETP) of Ruxolitinib in Patients With Polycythemia Vera Who Were Hydroxyurea Resistant or Intolerant and for Whom no Treatment Alternatives Was Available.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Expanded Treatment Protocol (ETP) of Ruxolitinib in Patients With Polycythemia Vera Who Were Hydroxyurea Resistant or Intolerant and for Whom no Treatment Alternatives Was Available.

Official Title: An Open-label, Multi-center, Expanded Treatment Protocol (ETP) of Ruxolitinib in Patients With Polycythemia Vera Who Are Hydroxyurea Resistant or Intolerant and for Whom no Treatment Alternatives Are Available.

Study ID: NCT02292446

Interventions

Ruxolitinib

Study Description

Brief Summary: The purpose of this open-label, single arm, multi-center Expanded Treatment Protocol (ETP) was to provide early access to ruxolitinib and evaluate safety information in patients with polycythemia vera (PV) who were hydroxyurea (HU) resistant or intolerant and who had no other standard treatment option, nor did they qualify for another clinical study for PV

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Novartis Investigative Site, Linz, , Austria

Novartis Investigative Site, Salzburg, , Austria

Novartis Investigative Site, Wels, , Austria

Novartis Investigative Site, Antwerp, , Belgium

Novartis Investigative Site, Brugge, , Belgium

Novartis Investigative Site, Bruxelles, , Belgium

Novartis Investigative Site, Leuven, , Belgium

Novartis Investigative Site, Liege, , Belgium

Novartis Investigative Site, Yvoir, , Belgium

Novartis Investigative Site, Pleven, , Bulgaria

Novartis Investigative Site, Plovdiv, , Bulgaria

Novartis Investigative Site, Sofia, , Bulgaria

Novartis Investigative Site, Sofia, , Bulgaria

Novartis Investigative Site, Vancouver, British Columbia, Canada

Novartis Investigative Site, Hamilton, Ontario, Canada

Novartis Investigative Site, Vina del Mar, Valparaiso, Chile

Novartis Investigative Site, Santiago, , Chile

Novartis Investigative Site, Santiago, , Chile

Novartis Investigative Site, Bayonne, Bayonne Cedex, France

Novartis Investigative Site, Le Mans, Cedex 09, France

Novartis Investigative Site, Angers Cedex 1, , France

Novartis Investigative Site, Avignon cedex 9, , France

Novartis Investigative Site, Bordeaux, , France

Novartis Investigative Site, Chambéry Cedex, , France

Novartis Investigative Site, Marseille, , France

Novartis Investigative Site, Meaux cedex, , France

Novartis Investigative Site, Metz, , France

Novartis Investigative Site, Mulhouse cedex, , France

Novartis Investigative Site, Nice Cedex, , France

Novartis Investigative Site, Paris, , France

Novartis Investigative Site, Perpignan, , France

Novartis Investigative Site, Pringy cedex, , France

Novartis Investigative Site, Toulouse Cedex 9, , France

Novartis Investigative Site, Vandoeuvre Les Nancy, , France

Novartis Investigative Site, Villejuif Cedex, , France

Novartis Investigative Site, Mannheim, Baden-Wuerttemberg, Germany

Novartis Investigative Site, Aschaffenburg, , Germany

Novartis Investigative Site, Augsburg, , Germany

Novartis Investigative Site, Bad Soden, , Germany

Novartis Investigative Site, Berlin, , Germany

Novartis Investigative Site, Bottrop, , Germany

Novartis Investigative Site, Eisenach, , Germany

Novartis Investigative Site, Erlangen, , Germany

Novartis Investigative Site, Frankfurt, , Germany

Novartis Investigative Site, Frankfurt, , Germany

Novartis Investigative Site, Friedrichshafen, , Germany

Novartis Investigative Site, Hamburg, , Germany

Novartis Investigative Site, Hamm, , Germany

Novartis Investigative Site, Heidelberg, , Germany

Novartis Investigative Site, Heilbronn, , Germany

Novartis Investigative Site, Koblenz, , Germany

Novartis Investigative Site, Mutlangen, , Germany

Novartis Investigative Site, Stuttgart, , Germany

Novartis Investigative Site, Wuerzburg, , Germany

Novartis Investigative Site, Monterrey, Nuevo Leon, Mexico

Novartis Investigative Site, Fredrikstad, , Norway

Novartis Investigative Site, Tromso, , Norway

Novartis Investigative Site, Lisboa, , Portugal

Novartis Investigative Site, Lisboa, , Portugal

Novartis Investigative Site, Lulea, , Sweden

Novartis Investigative Site, Uddevalla, , Sweden

Novartis Investigative Site, Khon Kaen, THA, Thailand

Novartis Investigative Site, Bangkok, , Thailand

Novartis Investigative Site, Bangkok, , Thailand

Novartis Investigative Site, Chiang Mai, , Thailand

Contact Details

Name: Novartis Pharmaceuticals

Affiliation: Novartis Pharmaceuticals

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: